VEGFR2/CD309 antibody (Extracellular Domain)
Quick Overview for VEGFR2/CD309 antibody (Extracellular Domain) (ABIN1493515)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular Domain
-
Specificity
- Human. No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross reactivity with other proteins.
-
Purification
- Affinity purified
-
Immunogen
-
Recombinant human extracellular domain of VEGFR-2 (KDR).
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- 1.2 % sodium acetate or neutral PBS.
-
Concentration
- Lot specific
-
Buffer
- 1.2 % sodium acetate, 2 mg BSA, 0.01 mg sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short term: 4°C
Long term: -20°C.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- KDR / VEGFR2
-
Background
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
Gene ID
- 3791
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-